Compounds > phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2
Page last updated: 2024-09-03

phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and glucagon

phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 has been researched along with glucagon in 1 studies

Compound Research Comparison

Studies
(phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2)		Trials
(phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2)		Recent Studies (post-2010)
(phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2)		Studies
(glucagon)		Trials
(glucagon)		Recent Studies (post-2010) (glucagon)
170126,0391,4983,054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, RZ; Karashima, T; Schally, AV1

Other Studies

1 other study(ies) available for phe-cyclo(cys-tyr-trp-lys-val-cys)thr-nh2 and glucagon

ArticleYear
Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Life sciences, 1987, Aug-24, Volume: 41, Issue:8

    Topics: Animals; Chlorpromazine; Depression, Chemical; Glucagon; Growth Hormone; Insulin; Insulin Secretion; Islets of Langerhans; Male; Morphine; Octreotide; Phenobarbital; Pituitary Gland, Anterior; Rats; Secretory Rate; Somatostatin

1987